Purchase this article with an account.
Andreas Goldwich, C. Ross Ethier, Darren W.-H. Chan, Ernst R. Tamm; Perfusion with the Olfactomedin Domain of Myocilin Does Not Affect Outflow Facility. Invest. Ophthalmol. Vis. Sci. 2003;44(5):1953-1961. doi: 10.1167/iovs.02-0863.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
purpose. Mutations in the MYOC gene coding for myocilin are associated with elevated intraocular pressure (IOP), and recombinant myocilin, produced in a prokaryotic expression system, has been reported to affect aqueous outflow facility. This study was conducted to test whether perfusion with a fragment of recombinant myocilin (containing the full-length olfactomedin domain), produced in a eukaryotic expression system, affects facility.
methods. 293 EBNA cells were transfected by a vector containing the BM40 signal peptide, a human cDNA coding for myocilin, and a polyhistidine tag (HisTag) sequence. Recombinant protein was isolated by Ni-chelate chromatography, and characterized, and perfused into cultured anterior segments of human and porcine eyes.
results. Recombinant myocilin was secreted as a ∼55-kDa intact protein and two fragments arising from cleavage of the recombinant protein at amino acid 215. The C-terminal fragment, containing the entire olfactomedin domain, was successfully isolated. When perfused into human and porcine eyes, this C-terminal fragment did not appreciably affect outflow facility.
conclusions. Although the olfactomedin domain appears to be important for the function of myocilin, perfusion with a recombinant myocilin fragment containing this domain does not change outflow facility. It is possible that both the olfactomedin and N-terminal domains (including the leucine zipper) must be present for myocilin to have full function. Alternatively, posttranslational modifications of myocilin may have a major impact on protein function.
This PDF is available to Subscribers Only